(4-Hydroxy-3-methylphenyl)(phenyl)methanone, 97%, 1g

Ethyl 3-tert-butyl-1H-pyrazole-5-carboxylate, 98.0%, 5g

1-(2-Bromo-6-fluoro-3-methoxyphenyl)-N-methylmethanamine, 95%, 100mg

2-Chloro-pyridine-3-yl-acetic acid, 97.0%, 1g

Single-channel microliter pipette ROTILABO®, 100 to 1000 µl, 1 piece

(3R)-2-tert-Butoxycarbonyl-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid, 97.0%, 100g

2-Fluoro-4-methylphenylacetic acid, 95.0%, 1g

1-Methyl-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole, 95.0%, 250mg

2-cyclopropyl-7-azaindole, 95.0%, 250mg

2-Oxo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile, 95.0%, 1g

Larotrectinib, 97%, 250mg

2,5-DIFLUORO-4-(TRIFLUOROMETHYL)BENZONITRILE, 95.0%, 1g

3-Hydroxy-2-methylpyridine, 98.0%, 100g